Literature DB >> 1483071

The architecture of cancer.

J Waxman, H Wasan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1483071      PMCID： PMC1883897          DOI： 10.1136/bmj.305.6865.1306

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  23 in total

1.  A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas.

Authors:  P Basset; J P Bellocq; C Wolf; I Stoll; P Hutin; J M Limacher; O L Podhajcer; M P Chenard; M C Rio; P Chambon
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

2.  In vivo and in vitro invasiveness of human lung carcinoma cell lines.

Authors:  S Momiki; M Baba; J Caamano; T Iizasa; M Nakajima; Y Yamaguchi; A Klein-Szanto
Journal:  Invasion Metastasis       Date:  1991

3.  Regulation of kinesin expression and type IV collagenase secretion in invasive human prostate PC-3 tumor sublines.

Authors:  M E Stearns; M Wang
Journal:  Cancer Res       Date:  1991-11-01       Impact factor: 12.701

4.  Increased proteinase expression during tumor progression of cell lines down-modulated for TIMP levels: a new transformation paradigm? [corrected].

Authors:  R Khokha; P Waterhouse; P Lala; M Zimmer; D T Denhardt; R Khokka
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

5.  Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases.

Authors:  K A Hasty; T F Pourmotabbed; G I Goldberg; J P Thompson; D G Spinella; R M Stevens; C L Mainardi
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

6.  Decreased expression of tissue inhibitor of metalloproteinases in metastatic tumor cells leading to increased levels of collagenase activity.

Authors:  A Ponton; B Coulombe; D Skup
Journal:  Cancer Res       Date:  1991-04-15       Impact factor: 12.701

7.  Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells.

Authors:  P Huhtala; A Tuuttila; L T Chow; J Lohi; J Keski-Oja; K Tryggvason
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

8.  Malignant cell-specific gelatinase activity in human endometrial carcinoma.

Authors:  M Takemura; C Azuma; T Kimura; Y Tokugawa; M Miki; M Ono; F Saji; O Tanizawa
Journal:  Cancer       Date:  1992-07-01       Impact factor: 6.860

9.  Evaluation of basement membrane components and the 72 kDa type IV collagenase in serous tumors of the ovary.

Authors:  E Campo; M J Merino; F A Tavassoli; A S Charonis; W G Stetler-Stevenson; L A Liotta
Journal:  Am J Surg Pathol       Date:  1992-05       Impact factor: 6.394

10.  Inhibition of collagenolytic activity in human leukemic K562 cells by tamoxifen.

Authors:  M G Akeli; C Madoulet; A Rallet; J C Jardillier
Journal:  Leuk Res       Date:  1991       Impact factor: 3.156
View more
  3 in total

Review 1.  The matrix metalloproteinases and their inhibitors in pancreatic cancer. From molecular science to a clinical application.

Authors:  S R Bramhall
Journal:  Int J Pancreatol       Date:  1997-02

2.  Architecture of cancer.

Authors:  A K Nigam
Journal:  BMJ       Date:  1993-01-30

3.  Serum metalloproteinases and their inhibitors: markers for malignant potential.

Authors:  T Baker; S Tickle; H Wasan; A Docherty; D Isenberg; J Waxman
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.